Asher Biotherapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
650 Gateway Blvd. Suite 100 South, South...Phone Number
(650) 416-6789Website
www.asherbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Asher Biotherapeutics
Asher Biotherapeutics, found in 2019 and based in South San Francisco, is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. The cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types.Explore more
Asher Biotherapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Asher Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Asher Biotherapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Asher Biotherapeutics
Product Launch: Get notified when Asher Biotherapeutics launches new products
Click to see if Asher Biotherapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Asher Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Asher Biotherapeutics recently announced quarterly report
Check out if Asher Biotherapeutics is spiking on competitors!
Check if Asher Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Asher Biotherapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Asher Biotherapeutics
Compare insights from companies similar to Asher Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.1M
11-50
Private
$80M
2015
SB
Shiva BolourchiHead Vice President, Corporate Strategy & Program Leadership
Company Profile Activity
Activity Insights
Asher Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Asher Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Asher Biotherapeutics.
Asher Biotherapeutics financials insights
Gather financial insights about Asher Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$55M
Series B
$108M
2024
Series C
$55M
Asher Biotherapeutics Tech Stack
A closer look at the technologies used by Asher Biotherapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Partnership
Partnership, Research & Development, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Funding
Funding
Open Position
Asher Biotherapeutics News & Media
Asher Bio Announces Clinical Trial Collaboration and Supply Agreement on Etakafusp Alfa (AB248) in Combination with Bispecific T-cell Engager in Patients with Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer and infectious diseases, today announced a clinical trial collaboration and supply agreement with Amgen (NASDAQ:AMGN) to evaluate etakafusp alfa (formerly known as AB248), Asher Bio’s investigational CD8+ T cell targeted interleukin-2 (IL-2) immunotherapy, in combination with IMDELLTRA® (tarlatamab), Amgen’s DLL3-targeting Bispecific T-cell EngageAsher Bio Announces Clinical Supply Agreement to Enable Evaluation of Etakafusp Alfa (AB248) in Combination with Rilvegostomig in a Global Phase 1b/2 Study in Non-Small Cell Lung Cancer (NSCLC)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer and infectious diseases, today announced an agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) to supply etakafusp alfa (formerly known as AB248), Asher Bio’s investigational CD8+ T cell targeted interleukin-2 (IL-2) immunotherapy, to be evaluated in combination with rilvegostomig, AstraZeneca’s investigational PD-1/TIGIT immuno-oncology bispecificSeries C - Asher Bio - 2024-04-16 - Crunchbase Funding Round Profile
Asher Bio raised $55000000 on 2024-04-16 in Series CAsher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today announced the closing of a Series C financing, which raised $55 million. The financing was led by RA Capital Management, and included new investors AstraZeneca (LSE/STO/Nasdaq: AZN) and Bristol Myers Squibb, along with existing investors Janus Henderson Investors, Third Rock Ventures, Wellington Manageme
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Asher Biotherapeutics
Sign Up For FreeTo access detailed company insights
Asher Biotherapeutics, found in 2019 and based in South San Francisco, is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. The cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that... Read More
